BIBW 2992 (Afatinib) and Vinorelbine
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Carcinoma Breast Stage IV
Interventions: DRUG: BIBW 2992 in combination with vinorelbine
Sponsor: University of Magdeburg
Collaborators: Boehringer Ingelheim